scholarly journals The assessment of returning to work following treatment and the associated personal, disease, and treatment factors among breast cancer survivors in central China

2021 ◽  
Author(s):  
Min Li ◽  
Jinnan Gao ◽  
Ming Li ◽  
Linying Wang
Keyword(s):  
Breast Cancer ◽  
Cancer Treatment ◽  
Breast Cancer Survivors ◽  
Tertiary Hospital ◽  
Axillary Node ◽  
Central China ◽  
The Status ◽  
Returning To Work ◽  
After Cancer

Abstract Purpose To assess the status of returning to work (RTW) following breast cancer treatment and to explore its associated factors among female patients. Methods Four-hundred-forty-two eligible patients admitted in a tertiary hospital since 2012 were followed up in 2018. Information about working status after treatment, date of RTW or reason for not RTW was obtained during a 30-min interview. Patients’ sociodemographic, disease, and treatment characteristics were retrieved from the hospital record. Overall prevalence rate and probability of RTW during the follow-up were estimated using Kaplan–Meier method. Factors associated with RTW were identified using regression analyses. Results Three-hundred-ninety-six patients (89.6%) completed the follow-up. The median follow-up was 31 months. Among them, 141 patents (35.6%) RTW of whom 68.1% (n = 96) were back within 12 months after cancer treatment. The reported reasons for not RTW included: prolonged fatigue, low self-esteem, lack of support from family and working unit, or voluntarily quitting. Patients aged under 50 years, being single, having higher level of education, not having extensive axillary node procedure, or without any comorbidities were more likely to RTW. Conclusion The rate of RTW after cancer treatment in this cohort was lower than those reported in others. Both personal and treatment factors were associated with RTW.

scholarly journals Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Ran Feng ◽  
Jingfeng Jing ◽  
Xiaojun Zhang ◽  
Ming Li ◽  
Jinnan Gao
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Survivors ◽  
Insurance Coverage ◽  
Central China ◽  
Axillary Lymph ◽  
Current Guideline ◽  
Curative Surgery ◽  
Post Surgery ◽  
Treatment Characteristics

Abstract Background Follow-up after curative surgery is increasingly recognized as an important component of breast cancer care. Although current guideline regulates the follow-ups, there are no relevant studies on the adherence to it in China. This study investigated the post-surgery follow-up and explored its association with patients, tumor and treatment characteristics. Methods A total of 711 patients underwent surgical treatment in Shanxi Bethune Hospital from March 2012 to May 2018 were included in this study. Baseline sociodemographic, tumor, and treatment characteristics were obtained from the hospital electronic medical records. The post-surgery follow-up was reviewed and assessed from the patient’s follow-up examination record. Factors associated with the first three-year follow up was evaluated using logistic regression analysis. Results The annual follow-up rate after surgery decreased gradually from 67.1% at the 1st year, 60.2% at the 3rd year to 51.9% at the 4th year, and 43.5% at the 5th year. Loss of follow-up during the first 3 years after surgery was significantly associated with older age (> 65 years), lower medical insurance coverage, axillary lymph node dissection, and less intensity of systemic treatment. Conclusion A significant downtrend of annual follow-up rate for breast cancer survivors was confirmed in this study. Loss of follow-up within the first 3 years after surgery was associated with both patient’s characteristics and treatment. These results will provide evidence to help clinicians to develop tailored patient management after curative surgery.

Association of cancer treatment with excess heart age among young breast cancer survivors.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 12081-12081
Author(s):  
Jacqueline B Vo ◽  
Shoshana M. Rosenberg ◽  
Philip Daniel Poorvu ◽  
Kathryn Jean Ruddy ◽  
Rulla Tamimi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Blood Pressure ◽  
Cancer Survivors ◽  
Cancer Treatment ◽  
Endocrine Therapy ◽  
Breast Cancer Survivors ◽  
Cvd Risk ◽  
Young Breast Cancer ◽  
Heart Age

12081 Background: Young women with breast cancer may be at increased risk for premature development of cardiovascular disease (CVD) in part due to their cancer treatment. Limited data are available on CVD risk among young breast cancer survivors. Methods: Women aged 30-40 years at diagnosis with stage 0-III breast cancer enrolled in a prospective cohort study of women diagnosed with breast cancer at ≤40 were eligible for inclusion in this analysis. Data were obtained from serial surveys and electronic medical records at breast cancer diagnosis and 5-year follow-up. We calculated “excess heart age,” which incorporates a CVD risk-based score (calculated using age, systolic blood pressure, blood pressure medication, diabetes, smoking, body mass index) to estimate the difference in years between an individual’s chronological age and their CVD-risk adjusted age. Multivariable logistic regression models (adjusting for age at diagnosis, stage, and race) were fitted to evaluate associations between treatment (radiation, endocrine therapy, anthracyclines, and trastuzumab) and having a change in excess heart age ≥2 years from baseline to 5 years. Results: Among 372 young breast cancer survivors, mean age at diagnosis was 36.6 (SD 2.89), 93% were white, and 79% were diagnosed with stage I or II breast cancer. Mean excess heart age was.32 (SD: 6.16) years at baseline, which declined to -.07 (SD 6.64) at 5-year follow-up (p=.17). At 5 years, 31% (n=114) of women experienced an increase of at least 2 years in their excess heart age since diagnosis, and their mean excess heart age was 4.34 years (range -9 to 30). In multivariable analyses, receipt of trastuzumab was associated with higher odds (OR: 1.68, 95% CI: 1.02-2.77) of experiencing an increase of ≥2 years in excess heart age between diagnosis and 5 years of follow-up. Endocrine therapy, anthracyclines, and radiation were not significantly associated with a change in excess heart age of ≥2 years at 5 years post-diagnosis. Conclusions: At 5 years post-diagnosis, approximately 1/3 of young breast cancer survivors experienced a change from baseline in their excess heart age of ≥2 years. Further research is warranted to confirm findings regarding trastuzumab and excess heart age, and potential effects on longer-term cardiac outcomes in this population. Extended follow-up of this cohort may further quantify CVD risk over time.[Table: see text]

CHANGES IN SOCIAL RELATIONSHIPS AFTER CANCER: EXPERIENCES OF WOMEN BREAST CANCER SURVIVORS

2021 ◽  
pp. 22-24
Author(s):  
Tushti Bhardwaj
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Social Relationships ◽  
Breast Cancer Survivors ◽  
Extended Family ◽  
Psychosocial Interventions ◽  
Long Run ◽  
Diagnosis Of Cancer ◽  
After Cancer

Introduction: Breast cancer is one of the most commonly seen cancers among women in India. The diagnosis of cancer brings numerous issues to the patients and their family. The physical and emotional concerns are quite frequently studied but changes in social relationship are yet not duly studied. The present research aims to study the changes in social relationships of the breast cancer survivors at different time intervals during their follow up period. Methods: This descriptive research studied a total of 90 breast cancer survivors in three groups. Data was collected using a mix of quantitative and qualitative approach. Quantitative data was collected through a number of variables on ve point scale and qualitative through self developed interview schedule. Results: The ndings reported that social functioning of the long term survivors (>2 years) was better as compared to those in initial follow up. The survivors in initial 6 months of follow up did not receive expected social support from their friends and neighbours. Conclusion: Social relationships of breast cancer survivors though improve in long run but they need emotional support from extended family and friends. The research has implications for psychosocial interventions to strengthen social network of the survivors.

scholarly journals Breast cancer survivors have less lean mass and lower phase angle after cancer treatment

Mastology ◽  
2019 ◽  
Vol 29 (4) ◽  
pp. 180-185
Author(s):  
Rute Mattos Dourado Esteves Justa ◽  
◽  
Vitória Maria Queiroz Machado ◽  
Carone Alves Lima ◽  
Ádila da Silva Castro ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Cancer Treatment ◽  
Phase Angle ◽  
Lean Mass ◽  
Breast Cancer Survivors ◽  
Lower Phase ◽  
After Cancer

scholarly journals Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis

2018 ◽  
Vol 17 (3) ◽  
pp. 636-645 ◽  
Author(s):  
M. Robyn Andersen ◽  
Erin Sweet ◽  
Shelly Hager ◽  
Marcia Gaul ◽  
Fred Dowd ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Cancer Survivors ◽  
Cancer Treatment ◽  
Breast Cancer Survivors ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

Objective: This study sought to describe changes in the health-related quality of life (HRQOL) of women who do and do not seek naturopathic oncology (NO) complementary and alternative medicine (CAM) care during and immediately after breast cancer treatment, and to explore the predictive role of NO CAM care, demographic characteristics, and involvement in decision-making on HRQOL in breast cancer survivors. Methods: Matched cohorts of breast cancer survivors who did and did not choose to supplement their breast cancer treatment with NO care within 2 years of diagnosis participated. NO users were identified through naturopathic doctors’ clinics and usual care (UC) controls with similar prognosis were identified through a cancer registry. The registry provided information about all participants’ age, race, ethnicity, marital status, stage of cancer at time of diagnosis, date of diagnosis, and use of conventional medical treatments (surgery, chemotherapy, radiation, and endocrine therapy). Data of participants’ self-reported involvement in decision-making and HRQOL were collected at study enrollment and at 6-month follow-up. Results: At 6-month follow-up, the NO patients reported significantly more involvement in decision-making about care and better general health than did UC patients ( P < .05). Self-reported involvement in decision-making about cancer treatment was associated with better role-physical, role-emotional, and social-functional well-being ( P < .05). Race, age, marital status, and congruence of preferred and achieved levels of involvement also predicted aspects of HRQOL in breast cancer survivors ( P < .05). Conclusions: Both NO CAM care and involvement in decision-making about cancer treatment may be associated with better HRQOL in breast cancer survivors.

Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment

2014 ◽  
Vol 18 (3) ◽  
pp. 323-328 ◽  
Author(s):  
Winnie K.W. So ◽  
Ka Ming Chow ◽  
Helen Y.L. Chan ◽  
Kai Chow Choi ◽  
Rayman W.M. Wan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Cancer Treatment ◽  
Breast Cancer Survivors ◽  
Unmet Needs ◽  
One Year ◽  
After Cancer

scholarly journals Adherence to follow-up recommendation guidelines in long term breast cancer survivors, a SURBCAN cohort analysis using administrative databases

The Breast ◽  
2021 ◽  
Vol 56 ◽  
pp. S80-S81
Author(s):  
P. Santiá ◽  
A. Jansana ◽  
T. Sanz ◽  
I. de la Cura ◽  
M. Padilla-Ruiz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Cohort Analysis ◽  
Administrative Databases
Sign in / Sign up

Export Citation Format

Share Document